Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetracycline in Post-Treatment Lyme Disease (T4)
NCT05219929Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Nov 2022
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tetracycline in Post-Treatment Lyme Disease Syndrome (PTLDS), sponsored by Johns Hopkins University. Started Nov 2022; status: completed.
02
Drugs
tetracycline
03
Conditions
Post-Treatment Lyme Disease Syndrome (PTLDS)
Beyond the preview
Go deeper on NCT05219929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05219929.